CCR5 and neoplasm: In melanoma, tumor-infiltrating CCR5+ MDSCs was found to show elevated expression levels of immunosuppressive markers such as PD-L1, Arg1, ROS and NO, exerting stronger immunosuppressive activity compared with its CCR5- counterparts (12).